Business
Business And Economy In New York
New York Times building in Manhattan (Beata Zawrzel/Getty Images)
Weird Money

The New York Times is a games company with a newspaper side hustle

The Times now has more non-news subscribers than news-only subscribers.

Jack Raines

In October 2021, Reddit software engineer Josh Wardle published his newly created word game, “Wordle” (a play on words for his name), on his website, and the game reached 90 users by November 1. One month later, the game had 300,000 daily players, and a week after that, the number of daily players reached 2 million. Just three months after publishing his now-viral game online, Wardle sold Wordle to The New York Times for “low seven figures.”

At the time, the decision for a media company to spend millions to acquire a free game raised questions, but two years later, it looks like the Times’ bet on games and other alternative products has paid off. While the media industry of the 2020s has dealt with widespread layoffs and declining readership, The New York Times is doing better than ever. Its stock price just notched an all-time high, Q1 revenue increased by approximately $33 million year over year despite a decline in advertising revenue, and net income nearly doubled from $22 million to $40 million.

One reason that the Times has succeeded while other media companies have struggled is that the Times has focused on growing its non-media offerings over its news product. According to its Q1 2024 report, The New York Times now has more single-product subscribers for its non-news products — such as The Athletic, Cooking, Games, and Wirecutter — than it does news-only subscribers…

NYT's Q1 2024 earnings
NYT's Q1 2024 earnings

...and the number of other single-product subscribers this year outnumbers total bundled subscribers in December 2022 by 386,000. News-only subscribers have decreased by almost 40% since September 2022, while bundle and other single-product subscriptions have exploded.

NYT's Q2 2023 earnings
NYT's Q2 2023 earnings

Publishers across the media industry have tried to pivot from advertising-first to subscription-first models as social media has permanently disrupted the publisher-advertising business model, but readers are only willing to subscribe to so many publications, making subscription growth a tough problem to solve.

The Times’ strategy of building an increasingly diversified product suite for its subscribers has proven to be a genius solution. Most readers aren’t going to spend hundreds of dollars per publication to subscribe to The Times, The Washington Post, The Journal, The Atlantic, and countless other publications, but if you include crossword puzzles, spelling bees, and “easy weeknight” recipe guides with your subscription, some of those readers will opt for your publication over the competition.

Everyone talks about the pivot from physical to digital media, but I think the bigger shift in media has been advertisement-subsidized reporting to sudoku-subsidized reporting. Funny enough, the latter feels like a purer model, no?

More Business

See all Business
business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Hims oral semaglutide

Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy

It’s unclear if the pill Hims is selling works or if the FDA will allow it.

$1.3M

There’s still plenty of money to be made in brainrot. The top 1,000 Roblox creators earned an average of $1.3 million in 2025 — up 50% from the year prior — according to CEO Dave Baszucki on the company’s fourth-quarter earnings call.

Roblox paid out $1.5 billion to creators last year, meaning its top 1,000 creators took home about 87% of the total pool.

Like other creator economy giants, Roblox rewards its biggest creators for their contributions to user engagement. Creator-made titles like “Grow a Garden” and “Steal a Brainrot” substantially boosted playing time over the course of the year. In September, the company increased its developer exchange rate, or the ratio of in-game currency to cash payout, by 8.5%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.